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Introduction
The recent spread of e-cigarette use has spurred not only enthusiasm about their harm reduction and smoking cessation potential but also concerns about possible risks from long-term use, and stalled cessation through dual use.1 Another main concern is that e-cigarette use is increasing
among tobacco-naive youth2 than among only adult smokers who are using them for cessation and expectation of risk reduction.1 With youth
smoking at all-time lows in several nations with advanced tobacco control programs,3–5 there are therefore concerns that e-cigarettes may stall
or reverse these declines as youth who were likely to never use any form of nicotine become familiar with it, and start experimenting with
other forms of nicotine delivery.
These concerns were strengthened by the recent publication of a meta-analysis of longitudinal studies showing that e-cigarettes can serve as
a gateway to later cigarette smoking among nicotine-naive youth.6 They were also emphasized by the 2018 report of the National Academies
of Sciences, Engineering, and Medicine (NASEM),7 which concluded that such studies “provided “strong evidence of plausibility and specificity
of a possible causal effect of e-cigarette use on smoking…” with the Committee “consider[ing] the overall body of evidence of a causal effect
of e-cigarette use on risk of transition from never to ever smoking to be substantial” (pp. 16–32).
By contrast, Public Health England concluded, “Despite some experimentation with these devices among never smokers, e-cigarettes are
attracting very few young people who have never smoked into regular use”.8
Given the importance of putative gateway or “catalyst”9 effects in assessing the population impact of e-cigarettes, proponents of e-cigarettes were quick to criticize such evidence and their underlying gateway hypothesis.10–13 In the context of this debate, the gateway hypothesis
is adapted to denote the use of less harmful forms of nicotine delivery (eg, e-cigarettes), leading to the use of more harmful ones (eg, combustible cigarettes).7,10–13 We here present and respond to three major criticisms that have been made of e-cigarettes’ gateway potential based on
currently available evidence.

Downward Trends in Adolescent Smoking
Are Incompatible With a Gateway Effect for
E-cigarettes
Several prominent harm reduction proponents have argued that the
gateway hypothesis is incompatible with population trends in the
United States3 and United Kingdom4 of declining adolescent smoking. The argument here runs that vaping has been rising while smoking continues to fall, so vaping cannot be causing smoking to any
significant degree among adolescents.13
In both nations, declining trends of smoking among youth were
apparent well before the introduction of e-cigarettes.14–16 Moreover,
associations in population trends are known to be prone to the ecological fallacy; that is, what is true at the population level may not

be true at the individual level, especially when other population-level
attributes are not considered (eg, effective tobacco control policies).
Specifically, the ecological argument relies on an assumption that the
population net impact of any putative gateway effect of e-cigarette
use would be larger than the combined net impact of all other policies, programs, and factors that are responsible for reducing adolescent smoking prevalence (eg, tobacco tax and retail price, measures
of the denormalization of smoking, exposure of children to adulttargeted quit campaigns, retail display bans, health warnings, plain
packaging).17 This is an extremely high bar that gateway critics demand that anyone suggesting gateway effects needs to jump over.
The combined impact of such factors in preventing uptake could,
thereby, easily mask considerable smoking uptake that might not
have occurred in the absence of e-cigarettes.
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With smoking prevalence at record lows in the United States,
England, and Australia, only adequately powered longitudinal studies, which control for factors known to be associated with smoking uptake, are vital to examining potential gateway effects.9 Nine
such studies were included in a 2017 meta-analysis.6 Adjusting for
demographic, psychosocial, and behavioral risk factors for cigarette
smoking the meta-analysis showed that, the odds of subsequent cigarette smoking by nonsmokers who had any experience of vaping
more than tripled compared with those with no vaping experience.

Common Liability Rather Than Gateway?
One of the main criticisms of the gateway hypothesis lies in the difficulty in excluding other mechanisms for the observed relationship
between vaping and later cigarette smoking. The most commonly
proposed alternative explanation is based on the “common liability theory,”18 which emphasizes shared predisposing characteristics
among multidrug users. According to this hypothesis, a “propensity”
for drug use predicts multidrug use. Interestingly, however, several
longitudinal studies have reported the strongest association between
e-cigarette use and smoking initiation among youth with the lowest
risk of smoking.19–21 Moreover, recent evidence using national data
from the United States shows that a third of youth who start with
e-cigarettes have risk profiles that make them unlikely to start with
cigarettes.22
Rather than being mutually exclusive, the gateway and common
liability hypotheses are likely to be complementary. Common factors will explain the use of drugs in general, and specific factors will
explain why young people use specific drugs and in what contexts.23
This dynamic perception is in line with contemporary models of
behavioral change being dependent on the balance between intention and ability. Intention implies individual factors including any
propensity for drug use. However, such factors are contingent on
environmental conditions, such as access and feasibility of drug use
for intentions to be materialized.24
Indeed, the success of most tobacco control was the result of
targeting those potentiating environmental factors rather than some
innate propensity to use drugs. The salience of these environmental
factors is also evident from societal trends of smoking propagation in
response to tobacco industry marketing and obstruction of tobacco
control policies, as well as declines in smoking in response to successful implementation of effective population-based policies.17
The wide availability and intense marketing of e-cigarettes and
their low-risk appeal may coalesce to increasingly make e-cigarette
delivered nicotine the likely first drug on a multidrug cascade. But,
rather than be alarmed by these developments, e-cigarette proponents use this to argue against a specific temporal sequence needed
to establish causality. For example, Etter argues, “The temporal
sequence argument would not hold if the ordering of product use
was explained solely by the ordering of opportunities to use the
products, rather than by some inherent capacity of vaping to cause
smoking.”10 In reality, things are far more complicated, and relationships between risks (causes) and outcomes are complex, nonlinear,
and multidirectional.25 For example, obesity leads to joint stress, and
joint problems also potentiate obesity through reduced movement.
Which of these comes first and how they interact at different stages,
ages, and contexts is dynamic rather than static relationship.25
A recent study applying a prospective design and causal analytical
framework found a bidirectional association between e-cigarette use
and cigarette smoking among 11–18 year olds in Great Britain, yet
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the association was stronger from ever e-cigarettes use to cigarettes
initiation.26 So if e-cigarettes are a gateway into or away from other
drugs/tobacco in different situations that does not preclude causality
in both directions.
A recent NEJM review of the molecular basis of nicotine as a
gateway drug by the founder of the gateway hypothesis (Denise
Kandel) and her husband (Eric Kandel, 2000 Nobel Prize winner
in Medicine for neurophysiology) concluded that “nicotine acts as a
gateway drug on the brain, and this effect is likely to occur whether
the exposure is from smoking tobacco, passive tobacco smoke, or
e-cigarettes.”23 Although the biological basis of nicotine’s gateway
effect on the brain is likely to be consistent across different delivery
means, the manifestation of nicotine dependence can vary according
to different nicotine delivery methods (eg, sensory cues in e-cigarettes can be different from those of traditional cigarettes).
E-cigarette proponents often assert that vaping is demonstrably
a reverse gateway out of smoking for those who quit, while being
scathing about suggestions that it could ever be a gateway into
smoking.27 Soundbites like “kids who will try stuff, will try stuff”
and “kids who will smoke, will smoke” have been repeatedly used
as debate enders. Any cessation researcher offering the equally trite
“smokers who will quit, will quit” as a serious contribution to
understanding the complexity of transitioning out of smoking would
be rightly pilloried for their primitive understanding of the complex
processes that can culminate with permanent smoking cessation. Yet,
with e-cigarettes, all that is apparently required to be said about anyone who smokes regularly is that that they had a propensity to do
so. If this hard determinism was all that was needed to be invoked
in understanding smoking uptake, how then do we explain the dramatic falls in uptake that have been seen in nations that have robust,
comprehensive tobacco control programs? What eroded the “propensity” of all those who never took up smoking? Nicotine liability
may well be a predisposing factor, but what of the known tractable
reinforcing and enabling factors that tobacco control has so successfully identified and addressed over decades?

The Implausibility of Experimental Vaping
Transitioning to Smoking?
Another salient argument used by e-cigarette proponents is that
studies showing a gateway effect do not differentiate adolescent
experimental vaping from more regular use, so “any vaping” is
treated the same when the association between vaping and later cigarette smoking is assessed. Etter argued that it is “hardly plausible
that a simple puff or a few puffs on an e-cigarette can cause subsequent regular smoking.”10 But of course every regular smoker started
with a “simple puff,” nearly always in adolescence. They then typically progress through more regular use to daily smoking. Birge et al.
recently reported that over two thirds of smokers who tried as little
as a single puff became, for a time, regular smokers.28
Moreover, the assertion about the implausibility of experimental
e-cigarette use leading to regular smoking in youth contrasts with
an important body of evidence regarding the high susceptibility of
children and adolescents to the psychotropic and addictive effects of
nicotine. For example, Fidler et al.29 and others30 have highlighted
that children only require a very minimal exposure to develop an
important and identified “sleeper effect”: A vulnerability to smoking
after trying just a single cigarette, which can lie dormant for 3 years or
more: “From a neurobiological viewpoint, neural reward pathways
might be changed as a consequence of a single exposure to nicotine,
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thus potentially increasing vulnerability to later smoking uptake.”29
Others have referred to an established body of evidence relating to
youth nicotine exposure; “Importantly, several studies support that
a single drug exposure can lead to changes in synaptic strength that
are associated with learning and memory. The high susceptibility of
children and youth to the “neurobiological insult” of nicotine was
recently been highlighted in the US Surgeon General’s report on
the potential risks of nicotine and electronic cigarettes to youth.31
Ultimately, these cellular changes could underlie the long-lasting
effects of drugs.”30
McNeill, who has been persistently critical of gateway effects,13,32
coauthored two heavily cited articles that noted, “The first symptoms of nicotine dependence can appear within days to weeks of
the onset of occasional use, often before the onset of daily smoking.”33 Moreover, in a 30-month follow-up of the same subjects, it
was noted, “Symptoms of tobacco dependence commonly develop
rapidly after the onset of intermittent smoking, although individuals
differ widely in this regard. There does not appear to be a minimum
nicotine dose or duration of use as a prerequisite for symptoms to
appear. The development of a single symptom strongly predicted
continued use, supporting the theory that the loss of autonomy over
tobacco use begins with the first symptom of dependence.”34 The
clear contrast between the well-established understanding of cigarette smokers’ rapid onset of symptoms of nicotine dependence with
efforts to trivialize concerns about initial infrequent use of e-cigarettes is therefore noteworthy.
The NASEM report7 emphasizes that because the e-cigarette
phenomenon is relatively recent, “the majority of studies … lack
sufficient duration of follow-up to study the naturalistic cigarette
smoking progression sequence, which can involve a lengthy period
between ever use and reaching daily smoking.” Emerging longitudinal data should provide greater clarity on the extent to which
“ever” smoking after e-cigarette uptake converts to daily smoking.

Concluding Remarks
Schneider and Diehl in their e-cigarettes as “catalysts” model,9 given
prominent status in the NASEM report, reviewed features of vaping that make it both attractive to adolescents (perceived lower
health risks, attractive flavors, lower price, inconspicuous use, higher
acceptance among peers and others) and why “increasing familiarity
with nicotine could lead to … potential transition to tobacco smoking.” They offer several cogent and highly plausible reasons for such
transition that gateway opponents seldom consider. These include
(1) Accessibility: E-cigarettes and cigarettes are often sold alongside
one another. Adolescents who might otherwise never visit a tobacco
retailer and be exposed to retail promotions, discount offers, and
curiosity push cues would be thus now exposed and (2) Experience:
As they state, “Becoming used to the habitual and ritual procedures
of smoking such as poise, handling, smoke breaks and body language” may erode negative feelings about smoking in some adolescents and facilitate experimentation with cigarettes. To these we
can add the renormalization of the smoking “performance” through
e-cigarettes and erosion of indoor clean air policies with e-cigarettes,
which might encourage young people, who would not have otherwise done so, to experiment with smoking.35
Despite emphatic and repeated claims from transnational tobacco
companies over many years that they have no interest in targeting
young people to encourage uptake, it would be much in the commercial interests of both the vaping industry and the tobacco industry
(where all major companies now sell e-cigarettes) to promote such
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uptake by youth. A much-quoted 1984 RJ Reynolds tobacco document put this succinctly, “Younger adult smokers are the only source
of replacement smokers ... If younger adults turn away from smoking, the industry must decline, just as a population which does not
give birth will eventually dwindle.”36 With smoking prevalence by
youth being at record low levels in an increasing number of nations,
the major concern cannot but exist in both the cigarette and vaping
industries about the ever-diminishing cohort of young people entering the market. Enticing youth who do not smoke to think of vaping
as “safe smoking” may be an essential strategy for long-term survival
for both industries, given the major exodus from smoking by youth.
Strategies such as the retail placement of cigarettes with e-cigarettes,
retailer incentive promotions to encourage dual use, cross-branding,
and promotional activity in poorly regulated environments (especially
the Internet) are increasingly used to attract new young customers to e
cigarettes. We are probably looking at a fast-emerging picture of broadbased nicotine addiction, with a dominant industry (Big Tobacco) at
the helm through mergers and acquisitions providing several product
options to suit different sectors of that base. E-cigarettes’ availability,
low cost, and attractiveness to youth may make them an increasingly
likely first step on a possible cascade to other drugs including traditional cigarettes, a concern that has been validated by evidence from
a variety of studies. So, rather than being competitive, gateway and
common liability are likely complementary (ie, common factors can
explain the use of drugs in general, while specific factors can explain
why young people use certain drugs and in what sequence).23
The NASEM review’s7 categorization of the evidence for the role
of e-cigarettes in transitioning to cigarettes as being “strong” and
“substantial,” together with the undeniable commercial motivations
to attract youth into regular nicotine use (including dual use) should
be salutary. If Public Health England is correct that the number of
children, who have both taken up regular vaping and/or graduated to
smoking after first vaping, is currently low, then this may change in
response to industry marketing efforts. The public health test of the
importance of this if it occurs will be the absolute numbers involved.
The current evidence about this issue is limited by the short
time frame of the introduction of e-cigarettes into a market that
has other nicotine-based products, to fully understand their effects
on these products and their users. It is also limited by the fast evolution of e liquids, and their delivery technology, as well as the
scarcity of evidence regarding the potential effects of regulations
on the role of these products in the marketplace for nicotine.
Notwithstanding, the available evidence provides an unequivocal
cause for caution about e-cigarette role as a harm reduction product given the emerging evidence in support of their gateway potential for cigarette smoking.
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